News: BGF-backed MiP Diagnostics launches synthetic antibody solution for high sensitivity Covid-19 testing - Healthcare Newsdesk

News: BGF-backed MiP Diagnostics launches synthetic antibody solution for high sensitivity Covid-19 testing - Healthcare Newsdesk
healthcare-newsdesk.co.uk - Lisa Baker, Editor • 432d

BGF portfolio company, MIP Diagnostics Ltd. this week announced the launch of its COVID-19 nanoMIP for diagnostic sensors, a synthetic alternative to …

Read more on healthcare-newsdesk.co.uk

    Healthcare News - cover
    Magazine
    Avatar - Lisa Baker LLB - Private Account

    Lisa Baker LLB - Private Account flipped this story into Healthcare News•432d